Healthwell Acquisition Corp. I
HWELW
NASDAQ Capital Market0.00
USD
- -
- -
Healthwell Acquisition Corp. I
HWELW
(NASDAQ Capital Market)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Healthwell Acquisition Corp. I is a special purpose acquisition company (SPAC) primarily engaged in effecting mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with healthcare-related businesses. Its focus is on targeting companies within healthcare technology, tech-enabled healthcare services, and tech-enabled wellness sectors. Founded recently with its headquarters in Winnetka, Illinois, Healthwell operates primarily in the United States capital markets through its Nasdaq listing under ticker HWEL. The company does not manufacture or sell products directly but serves as a vehicle for acquiring and merging with operational healthcare businesses that provide innovative healthcare solutions. Healthwell’s core business involves raising capital through public offerings and using these funds to enter transformative business combinations with companies that leverage technology to advance healthcare outcomes. Recently, Healthwell announced a definitive business combination agreement with Starton Therapeutics Inc., a clinical-stage company developing proprietary continuous drug delivery technology aimed at improving treatment tolerability and outcomes for hematological malignancies such as multiple myeloma and chronic lymphocytic leukemia. This combination was structured to create a publicly traded entity with a focus on innovative therapeutic delivery platforms. However, as of late 2023, this merger was terminated by Starton Therapeutics due to the failure of closing conditions, prompting Healthwell to seek alternative acquisition targets. Healthwell continues to actively pursue strategic partnerships and acquisitions in the healthcare technology space to realize its business objectives. In addition to the attempted merger with Starton Therapeutics, Healthwell has positioned itself within the healthcare SPAC market with significant capital raised from its initial public offering of $250 million. The company anticipates leveraging its network, operational expertise, and capital resources to support future ventures and growth in healthcare technology businesses. Its strategic activities reflect an ongoing commitment to identifying and consolidating innovative healthcare companies with substantial growth potential. Overall, Healthwell Acquisition Corp. I operates as a publicly traded blank check company with a dedicated focus on facilitating strategic mergers and acquisitions in the healthcare technology arena, aiming to bring transformative healthcare businesses to capital markets while driving innovation in patient care solutions. The company’s headquarters is in Winnetka, Illinois, and it operates primarily in North America with a mandate to expand through targeted healthcare sector acquisitions.